Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
24 results
D3.166 - Attention-deficit/hyperactivity disorder (ADHD) in asthmatic children
D3.168 - Clinical Department of Allergy Center in Linköping
D3.169 - Paediatric Severe Acute Respiratory Infections in Malta: A Three-Year Review
D3.171 - Validation of the Kazakh Version of the Asthma Quality of Life Questionnaire (AQLQ) for Clinical Use in Adult Patients with Asthma
D3.173 - Switching from Dupilumab to Tezepelumab in a Child with Severe Asthma and Atopic Dermatitis: Clinical Considerations and Therapeutic Implications
D3.174 - Short-term tolerance of omlyclo, the omalizumab biosimilar
D3.175 - Algorithm for Biologics Selection in Severe Asthma
D3.178 - Assessment of blood rheological properties in children with bronchial asthma
D3.179 - Longitudinal breath profiling of exhaled volatile organic compounds differentiates viral-induced asthma exacerbation from clinical control
D3.80 - Molecular allergy profiling of sensitization in adult patients with asthma in real practice
D3.84 - Patterns of Sensitization to Artemisia and Ambrosia Pollen in Ukraine
D3.90 - Outcomes of Beta-Lactam Allergy Evaluation in Patients with Suspected Hypersensitivity: One-Year Experience
D3.78 - Association between lipocalin sensitization and clinical symptoms: Evidence for cross-reactivity
D3.79 - Patterns of House Dust Mite Hypersensitivity in Eastern Ukraine
D3.81 - Allergic Contact Dermatitis Induced by Transdermal Estradiol Hormone Replacement Therapy in a Postmenopausal Patient: A Case Report
D3.82 - Conceptualization of a questionnaire for clinical diagnosis of house dust mite’s allergy
D3.83 - A Case Report of Fenofibrate-Induced Fixed Drug Eruption Documented by Patch Testing and Oral Provocation
D3.85 - Estrogen-Induced Drug Hypersensitivity Syndrome in a Patient with HHV-6 Reactivation
D3.86 - ALEX versus ISAC. The same story or an improvement for allergologic molecular diagnostic?
D3.87 - Evaluation of CD63 as a Marker of Basophil Degranulation in the Assessment of IgE-mediated Allergic Immune Responses
Pagination
Current page
1
Page
2
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download